Sensitive ASX Announcement

Opthea Ph1 wAMD Trial with OPT-302 Meets Primary Objective

Published: 21/04/16, 09:32am (AEST)3 pages
Opthea Limited
OPT:ASXHealthcare

Recent OPT Announcements

Price Sensitive only